Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab
Open Access
- 1 March 2004
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (3), 186-194
- https://doi.org/10.1016/j.bbmt.2003.11.001
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemiaBone Marrow Transplantation, 2003
- Non-myeloablative stem cell transplants. AnnotationBritish Journal of Haematology, 2000
- High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantationBone Marrow Transplantation, 2000
- Resistance to Antiviral Drugs in Herpes Simplex Virus Infections among Allogeneic Stem Cell Transplant Recipients: Risk Factors and Prognostic SignificanceThe Journal of Infectious Diseases, 2000
- Adenovirus Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 1999
- Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapyBone Marrow Transplantation, 1999
- Adenovirus infection after pediatric bone marrow transplantationBone Marrow Transplantation, 1999
- High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporineBone Marrow Transplantation, 1998
- Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infectionBone Marrow Transplantation, 1997
- Adenovirus Infections in Patients Undergoing Bone-Marrow TransplantationNew England Journal of Medicine, 1985